295 related articles for article (PubMed ID: 16317694)
1. A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis.
Laleman W; Omasta A; Van de Casteele M; Zeegers M; Vander Elst I; Van Landeghem L; Severi T; van Pelt J; Roskams T; Fevery J; Nevens F
Hepatology; 2005 Dec; 42(6):1382-90. PubMed ID: 16317694
[TBL] [Abstract][Full Text] [Related]
2. Basal release of nitric oxide in the mesenteric artery in portal hypertension and cirrhosis: role of dimethylarginine dimethylaminohydrolase.
Serna E; Mauricio MD; Lluch P; Segarra G; Cortina B; Lluch S; Medina P
J Gastroenterol Hepatol; 2013 May; 28(5):880-6. PubMed ID: 23302093
[TBL] [Abstract][Full Text] [Related]
3. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
Segarra G; Cortina B; Mauricio MD; Novella S; Lluch P; Navarrete-Navarro J; Noguera I; Medina P
World J Gastroenterol; 2016 Dec; 22(48):10545-10556. PubMed ID: 28082806
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats.
Yang YY; Lee TY; Huang YT; Chan CC; Yeh YC; Lee FY; Lee SD; Lin HC
Liver Int; 2012 Jan; 32(1):48-57. PubMed ID: 22098317
[TBL] [Abstract][Full Text] [Related]
5. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
[TBL] [Abstract][Full Text] [Related]
6. Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats.
Verbeke L; Farre R; Trebicka J; Komuta M; Roskams T; Klein S; Elst IV; Windmolders P; Vanuytsel T; Nevens F; Laleman W
Hepatology; 2014 Jun; 59(6):2286-98. PubMed ID: 24259407
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide modulates acetylcholine-induced vasodilatation in the hepatic arterial vasculature of the dual-perfused rat liver.
Yang W; Benjamin IS; Alexander B
Acta Physiol Scand; 2001 Apr; 171(4):413-8. PubMed ID: 11421856
[TBL] [Abstract][Full Text] [Related]
8. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis.
Anegawa G; Kawanaka H; Yoshida D; Konishi K; Yamaguchi S; Kinjo N; Taketomi A; Hashizume M; Shimokawa H; Maehara Y
Hepatology; 2008 Mar; 47(3):966-77. PubMed ID: 18167063
[TBL] [Abstract][Full Text] [Related]
9. ADMA correlates with portal pressure in patients with compensated cirrhosis.
Vizzutti F; Romanelli RG; Arena U; Rega L; Brogi M; Calabresi C; Masini E; Tarquini R; Zipoli M; Boddi V; Marra F; Laffi G; Pinzani M
Eur J Clin Invest; 2007 Jun; 37(6):509-15. PubMed ID: 17537159
[TBL] [Abstract][Full Text] [Related]
10. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.
Lluch P; Segarra G; Medina P
World J Gastroenterol; 2015 Aug; 21(32):9466-75. PubMed ID: 26327755
[TBL] [Abstract][Full Text] [Related]
12. Gastric mucosal resistance to acute injury in experimental portal hypertension.
Calatayud S; Ramírez MC; Sanz MJ; Moreno L; Hernández C; Bosch J; Piqué JM; Esplugues JV
Br J Pharmacol; 2001 Jan; 132(1):309-17. PubMed ID: 11156591
[TBL] [Abstract][Full Text] [Related]
13. Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension.
Mookerjee RP; Mehta G; Balasubramaniyan V; Mohamed Fel Z; Davies N; Sharma V; Iwakiri Y; Jalan R
J Hepatol; 2015 Feb; 62(2):325-31. PubMed ID: 25152204
[TBL] [Abstract][Full Text] [Related]
14. Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability.
Lee KC; Yang YY; Huang YT; Lee FY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2010 Apr; 119(1):45-55. PubMed ID: 20132096
[TBL] [Abstract][Full Text] [Related]
15. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of inducible nitric oxide synthase in gastric mucosa of rats with portal hypertension: correlation with gastric mucosal damage.
Hsieh JS; Wang JY; Lin SR; Lian ST; Chen FM; Hsieh MC; Huang TJ
J Surg Res; 2003 Nov; 115(1):24-32. PubMed ID: 14572769
[TBL] [Abstract][Full Text] [Related]
18. The dimethylarginine (ADMA)/nitric oxide pathway in the brain and periphery of rats with thioacetamide-induced acute liver failure: Modulation by histidine.
Milewski K; Hilgier W; Albrecht J; Zielińska M
Neurochem Int; 2015 Sep; 88():26-31. PubMed ID: 25523831
[TBL] [Abstract][Full Text] [Related]
19. The action of nitric oxide on hepatic haemodynamics during secondary biliary cirrhosis in the rat.
Yang W; Benjamin IS; Moore K; Portmann B; Alexander B
Eur J Pharmacol; 2003 Feb; 461(1):41-8. PubMed ID: 12568914
[TBL] [Abstract][Full Text] [Related]
20. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats.
Luo B; Liu L; Tang L; Zhang J; Ling Y; Fallon MB
Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G294-303. PubMed ID: 14715521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
